BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Average Recommendation of “Moderate Buy” by Brokerages
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month target price among […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month target price among […]
